BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15822775)

  • 1. [The local recurrence of renal-cell carcinoma after nephron-sparing surgery].
    Iliukhin IuA; Shchukin DV
    Voen Med Zh; 2005 Feb; 326(2):32-7, 80. PubMed ID: 15822775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
    Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
    J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephron-sparing therapy for renal tumors].
    Brehmer B; Mahnke AH; Jakse G
    Aktuelle Urol; 2007 Mar; 38(2):126-31; discussion 125. PubMed ID: 17390274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imperative and elective indications for nephron-sparing surgery for renal tumors: long-term oncological follow-up.
    Roos FC; Pahernik S; Brenner W; Thüroff JW
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S70-6. PubMed ID: 20094960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: experience in 107 patients.
    Lapini A; Serni S; Minervini A; Masieri L; Carini M
    J Urol; 2005 Jul; 174(1):57-60; discussion 60. PubMed ID: 15947577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Local recurrence after organ saving kidney tumor surgery].
    Brkovic D; Riedasch G; Waldherr R; Röhl L; Staehler G
    Urologe A; 1994 Mar; 33(2):104-9. PubMed ID: 8178403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Partial elective nephrectomy].
    Zungri E; Martínez L; Leal D; Lorenzo L
    Actas Urol Esp; 2012 Mar; 36(3):160-4. PubMed ID: 21955560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenchyma-conserving surgery for renal cell carcinoma.
    Taari K; Salo JO; Rannikko S; Kärkkäinen P; Nordling S; Lehtonen T
    Ann Chir Gynaecol Suppl; 1993; 206():54-8. PubMed ID: 8291871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
    Pertia A; Managadze L; Chkhotua A
    Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enucleoresection for the elective treatment of small renal cell carcinoma: can it be the treatment of choice?
    Adamakis I; Koutalellis G; Mitropoulos D; Vourekas S; Constantinides C; Zervas A
    Onkologie; 2007 Mar; 30(3):97-102. PubMed ID: 17341895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
    Hafez KS; Novick AC; Butler BP
    J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative surgery for renal cell carcinoma.
    Terrone C; Favro M; Neira D; Rocca Rossetti S
    Ann Urol (Paris); 1997; 31(3):137-44. PubMed ID: 9251830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The indications for partial nephrectomy in the treatment of renal cell carcinoma.
    Joniau S; Vander Eeckt K; Van Poppel H
    Nat Clin Pract Urol; 2006 Apr; 3(4):198-205. PubMed ID: 16607368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with nephron-sparing surgery in the presence of a normal contralateral kidney.
    Steinbach F; Stöckle M; Hohenfellner R
    Semin Urol Oncol; 1995 Nov; 13(4):288-91. PubMed ID: 8595553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
    Hafez KS; Novick AC; Campbell SC
    J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological outcomes of nephron sparing nephrectomy. 17-year analysis.
    Aguilera Bazan A; Bañuelos B; Alonso-Dorrego JM; Diez J; Cisneros J; De la Peña Barthel J
    Arch Esp Urol; 2014 Apr; 67(3):237-42. PubMed ID: 24840588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.